ERSTEQ

AI-powered innovation for
transformative therapies

Unlock new frontiers in medicine—developing therapies that don’t just treat, but truly transform lives.

About us
Re-imagine
the way
of drug discovery

ERSTEQ is redefining drug discovery with AI and biology.
The proprietary AI platform uncovers and optimizes novel chemical matter with greater speed, efficiency, and precision.
ERSTEQ is committed to delivering novel therapies with significantly improved clinical outcomes—for the lasting benefit of patients worldwide.

History

From the beginning
to breakthroughs

2025
  • Actively engaging in open innovation with biotech and pharmaceutical companies.
  • Currently in discussion with several domestic pharmaceuticals for R&D Collaboration.
  • EST-101001 European Patent Application.
2024
  • R&D Collaboration with JD Bioscience Inc.
  • R&D Collaboration with KRICT

  • Selected for

    - Rapid Support program for Sustainable Growth of lndustry in INNOPOLlS Daedeokby the Korea Innovation Foundation (KIF)

    - Data Voucher Support Program by the Korea Data Agency (KDATA)

    - Medical Research Center by the National Research Foundation (NRF)

  • EST-101001 Japanese Patent Application
2023
  • R&D Collaboration with KIOM, CNU, and KAIST
  • R&D Collaboration with Y-Biologics Inc.
  • Women’s Enterprise Certification

  • Awarded Multiple government-funded R&D projects, including

    - Global Corporate Collaboration Program (KISED)

    - Industry-Academia-Research Collaboration R&D Program (MSS)

    - Collaboration Platform of the Technology-Commercialization for lndustry in
    INNOPOLlS Daedeok (Daejeon Technopark; DJTP)

  • R&D Collaboration with LigaChem Biosciences Inc.
  • 2023 Digital Innovation Grant Awards
2022
  • Pre-series A Investment
  • Research Institutes Certification
  • Selected for TIPS Commercialization by the Korea Institute of Startup and
    Entrepreneurship Development (KISED)
  • 2022 Korea Company Grand Awards for AI drug discovery
2021
  • ERSTEQ Co., Ltd. founded
  • Seed Investment
  • Selected for TIPS R&D by the Ministry of SMEs and Startups (MSS)
  • Venture Business Certification
  • MOU with eFlask Co., Ltd.